Does TOFACITINIB Cause Herpes zoster? 3,575 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 3,575 reports of Herpes zoster have been filed in association with TOFACITINIB (XELJANZ XR). This represents 2.3% of all adverse event reports for TOFACITINIB.
3,575
Reports of Herpes zoster with TOFACITINIB
2.3%
of all TOFACITINIB reports
93
Deaths
596
Hospitalizations
How Dangerous Is Herpes zoster From TOFACITINIB?
Of the 3,575 reports, 93 (2.6%) resulted in death, 596 (16.7%) required hospitalization, and 108 (3.0%) were considered life-threatening.
Is Herpes zoster Listed in the Official Label?
Yes, Herpes zoster is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Herpes zoster?
ADALIMUMAB (3,783)
ETANERCEPT (3,129)
METHOTREXATE (2,589)
RITUXIMAB (2,228)
INFLIXIMAB (2,081)
LENALIDOMIDE (1,762)
TOCILIZUMAB (1,676)
OCRELIZUMAB (1,433)
ABATACEPT (1,395)
PREDNISONE (1,362)
Which TOFACITINIB Alternatives Have Lower Herpes zoster Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN